Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Classifying recurrent Mycobacterium tuberculosis cases in Georgia using MIRU-VNTR typing.

Maghradze N, Jugheli L, Borrell S, Tukvadze N, Aspindzelashvili R, Avaliani Z, Reither K, Gagneux S.

PLoS One. 2019 Oct 18;14(10):e0223610. doi: 10.1371/journal.pone.0223610. eCollection 2019.

2.

Rates and risk factors for nephrotoxicity and ototoxicity among tuberculosis patients in Tbilisi, Georgia.

Buziashvili M, Mirtskhulava V, Kipiani M, Blumberg HM, Baliashvili D, Magee MJ, Furin JJ, Tukvadze N, Kempker RR.

Int J Tuberc Lung Dis. 2019 Sep 1;23(9):1005-1011. doi: 10.5588/ijtld.18.0626.

PMID:
31615608
3.

High Yield of Active Tuberculosis Case Finding Among HIV-Infected Patients Using Xpert MTB/RIF Testing.

Kempker RR, Chkhartishvili N, Kinkladze I, Schechter MC, Harrington K, Rukhadze N, Dzigua L, Tserstvadze T, Del Rio C, Blumberg HM, Tukvadze N.

Open Forum Infect Dis. 2019 May 17;6(6):ofz233. doi: 10.1093/ofid/ofz233. eCollection 2019 Jun.

4.

High-resolution plasma metabolomics analysis to detect Mycobacterium tuberculosis-associated metabolites that distinguish active pulmonary tuberculosis in humans.

Collins JM, Walker DI, Jones DP, Tukvadze N, Liu KH, Tran VT, Uppal K, Frediani JK, Easley KA, Shenvi N, Khadka M, Ortlund EA, Kempker RR, Blumberg HM, Ziegler TR.

PLoS One. 2018 Oct 11;13(10):e0205398. doi: 10.1371/journal.pone.0205398. eCollection 2018.

5.

Mentoring in Global Health: Formative Evaluation of Tuberculosis Research Training Programs in Ethiopia and Georgia.

Comeau DL, Mishkin K, Tukvadze N, Avaliani Z, Kempker RR, Sthreshley L, Magee MJ, Eisen H, Mariam DH, Aseffa A, Blumberg HM.

Am J Trop Med Hyg. 2018 Sep;99(3):565-577. doi: 10.4269/ajtmh.17-0746. Epub 2018 Jul 12.

6.

The Impact of a Fogarty International Center-Supported Tuberculosis Research Training Program in the Country of Georgia.

Kempker RR, Tukvadze N, Sthreshley L, Sharling L, Comeau DL, Magee MJ, Del Rio C, Avaliani Z, Blumberg HM.

Am J Trop Med Hyg. 2018 Apr;98(4):1069-1074. doi: 10.4269/ajtmh.17-0667. Epub 2018 Feb 1.

7.

Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study.

Dorman SE, Schumacher SG, Alland D, Nabeta P, Armstrong DT, King B, Hall SL, Chakravorty S, Cirillo DM, Tukvadze N, Bablishvili N, Stevens W, Scott L, Rodrigues C, Kazi MI, Joloba M, Nakiyingi L, Nicol MP, Ghebrekristos Y, Anyango I, Murithi W, Dietze R, Lyrio Peres R, Skrahina A, Auchynka V, Chopra KK, Hanif M, Liu X, Yuan X, Boehme CC, Ellner JJ, Denkinger CM; study team.

Lancet Infect Dis. 2018 Jan;18(1):76-84. doi: 10.1016/S1473-3099(17)30691-6. Epub 2017 Nov 30. Erratum in: Lancet Infect Dis. 2018 Feb 21;:.

8.

Moxifloxacin target site concentrations in patients with pulmonary TB utilizing microdialysis: a clinical pharmacokinetic study.

Heinrichs MT, Vashakidze S, Nikolaishvili K, Sabulua I, Tukvadze N, Bablishvili N, Gogishvili S, Little BP, Bernheim A, Guarner J, Peloquin CA, Blumberg HM, Derendorf H, Kempker RR.

J Antimicrob Chemother. 2018 Feb 1;73(2):477-483. doi: 10.1093/jac/dkx421.

9.

The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing.

Chakravorty S, Simmons AM, Rowneki M, Parmar H, Cao Y, Ryan J, Banada PP, Deshpande S, Shenai S, Gall A, Glass J, Krieswirth B, Schumacher SG, Nabeta P, Tukvadze N, Rodrigues C, Skrahina A, Tagliani E, Cirillo DM, Davidow A, Denkinger CM, Persing D, Kwiatkowski R, Jones M, Alland D.

MBio. 2017 Aug 29;8(4). pii: e00812-17. doi: 10.1128/mBio.00812-17.

10.

Smoking behavior and beliefs about the impact of smoking on anti-tuberculosis treatment among health care workers.

Magee MJ, Darchia L, Kipiani M, Chakhaia T, Kempker RR, Tukvadze N, Berg CJ, Blumberg HM.

Int J Tuberc Lung Dis. 2017 Sep 1;21(9):1049-1055. doi: 10.5588/ijtld.17.0023. Epub 2017 Jun 29.

11.

Impact of gyrB and eis Mutations in Improving Detection of Second-Line-Drug Resistance among Mycobacterium tuberculosis Isolates from Georgia.

Bablishvili N, Tukvadze N, Shashkina E, Mathema B, Gandhi NR, Blumberg HM, Kempker RR.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e01921-16. doi: 10.1128/AAC.01921-16. Print 2017 Sep.

12.

Lung Tissue Concentrations of Pyrazinamide among Patients with Drug-Resistant Pulmonary Tuberculosis.

Kempker RR, Heinrichs MT, Nikolaishvili K, Sabulua I, Bablishvili N, Gogishvili S, Avaliani Z, Tukvadze N, Little B, Bernheim A, Read TD, Guarner J, Derendorf H, Peloquin CA, Blumberg HM, Vashakidze S.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e00226-17. doi: 10.1128/AAC.00226-17. Print 2017 Jun.

13.

pncA Gene Mutations Associated with Pyrazinamide Resistance in Drug-Resistant Tuberculosis, South Africa and Georgia.

Allana S, Shashkina E, Mathema B, Bablishvili N, Tukvadze N, Shah NS, Kempker RR, Blumberg HM, Moodley P, Mlisana K, Brust JC, Gandhi NR.

Emerg Infect Dis. 2017 Mar;23(3):491-495. doi: 10.3201/eid2303.161034.

14.

Development of the food supplement Nyaditum resae as a new tool to reduce the risk of tuberculosis development.

Tukvadze N, Cardona P, Vashakidze S, Shubladze N, Avaliani Z, Vilaplana C, Cardona PJ.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S101-S102. doi: 10.1016/j.ijmyco.2016.09.073. Epub 2016 Nov 14.

15.

Retrospective study of clinical and lesion characteristics of patients undergoing surgical treatment for Pulmonary Tuberculosis in Georgia.

Vashakidze S, Despuig A, Gogishvili S, Nikolaishvili K, Shubladze N, Avaliani Z, Tukvadze N, Casals M, Caylà JA, Cardona PJ, Vilaplana C.

Int J Infect Dis. 2017 Mar;56:200-207. doi: 10.1016/j.ijid.2016.12.009. Epub 2016 Dec 19. Review.

16.

Diabetes Reduces the Rate of Sputum Culture Conversion in Patients With Newly Diagnosed Multidrug-Resistant Tuberculosis.

Salindri AD, Kipiani M, Kempker RR, Gandhi NR, Darchia L, Tukvadze N, Blumberg HM, Magee MJ.

Open Forum Infect Dis. 2016 Jun 16;3(3):ofw126. doi: 10.1093/ofid/ofw126. eCollection 2016 Sep.

17.

The potential of a multiplex high-throughput molecular assay for early detection of first and second line tuberculosis drug resistance mutations to improve infection control and reduce costs: a decision analytical modeling study.

Van't Hoog AH, Bergval I, Tukvadze N, Sengstake S, Aspindzelashvili R, Anthony RM, Cobelens F.

BMC Infect Dis. 2015 Oct 26;15:473. doi: 10.1186/s12879-015-1205-4.

18.

High-dose vitamin D3 in adults with pulmonary tuberculosis: a double-blind randomized controlled trial.

Tukvadze N, Sanikidze E, Kipiani M, Hebbar G, Easley KA, Shenvi N, Kempker RR, Frediani JK, Mirtskhulava V, Alvarez JA, Lomtadze N, Vashakidze L, Hao L, Del Rio C, Tangpricha V, Blumberg HM, Ziegler TR.

Am J Clin Nutr. 2015 Nov;102(5):1059-69. doi: 10.3945/ajcn.115.113886. Epub 2015 Sep 23.

19.

Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis.

Kempker RR, Kipiani M, Mirtskhulava V, Tukvadze N, Magee MJ, Blumberg HM.

Emerg Infect Dis. 2015 Jun;21(6):992-1001. doi: 10.3201/eid2106.141873.

20.

The diagnostic targeting of a carbohydrate virulence factor from M.Tuberculosis.

Chan CE, Götze S, Seah GT, Seeberger PH, Tukvadze N, Wenk MR, Hanson BJ, MacAry PA.

Sci Rep. 2015 May 15;5:10281. doi: 10.1038/srep10281.

21.

Diabetes mellitus is associated with cavities, smear grade, and multidrug-resistant tuberculosis in Georgia.

Magee MJ, Kempker RR, Kipiani M, Gandhi NR, Darchia L, Tukvadze N, Howards PP, Narayan KM, Blumberg HM.

Int J Tuberc Lung Dis. 2015 Jun;19(6):685-92. doi: 10.5588/ijtld.14.0811.

22.

A comparison of the Xpert(®) MTB/RIF and GenoType(®) MTBDRplus assays in Georgia.

Bablishvili N, Tukvadze N, Avaliani Z, Blumberg HM, Kempker RR.

Int J Tuberc Lung Dis. 2015 Jun;19(6):676-8. doi: 10.5588/ijtld.14.0867.

23.

Cavitary penetration of levofloxacin among patients with multidrug-resistant tuberculosis.

Kempker RR, Barth AB, Vashakidze S, Nikolaishvili K, Sabulua I, Tukvadze N, Bablishvili N, Gogishvili S, Singh RS, Guarner J, Derendorf H, Peloquin CA, Blumberg HM.

Antimicrob Agents Chemother. 2015;59(6):3149-55. doi: 10.1128/AAC.00379-15. Epub 2015 Mar 16.

24.

Macronutrient intake and body composition changes during anti-tuberculosis therapy in adults.

Frediani JK, Sanikidze E, Kipiani M, Tukvadze N, Hebbar G, Ramakrishnan U, Jones DP, Easley KA, Shenvi N, Kempker RR, Tangpricha V, Blumberg HM, Ziegler TR.

Clin Nutr. 2016 Feb;35(1):205-12. doi: 10.1016/j.clnu.2015.02.007. Epub 2015 Feb 26.

25.

High-throughput mycobacterial interspersed repetitive-unit-variable-number tandem-repeat genotyping for Mycobacterium tuberculosis epidemiological studies.

Gauthier M, Bidault F, Mosnier A, Bablishvili N, Tukvadze N, Somphavong S, Paboriboune P, Ocheretina O, Pape JW, Paranhos-Baccala G, Berland JL.

J Clin Microbiol. 2015 Feb;53(2):498-503. doi: 10.1128/JCM.01611-14. Epub 2014 Nov 26.

26.

Plasma metabolomics in human pulmonary tuberculosis disease: a pilot study.

Frediani JK, Jones DP, Tukvadze N, Uppal K, Sanikidze E, Kipiani M, Tran VT, Hebbar G, Walker DI, Kempker RR, Kurani SS, Colas RA, Dalli J, Tangpricha V, Serhan CN, Blumberg HM, Ziegler TR.

PLoS One. 2014 Oct 15;9(10):e108854. doi: 10.1371/journal.pone.0108854. eCollection 2014.

27.

Significant clinical impact of a rapid molecular diagnostic test (Genotype MTBDRplus assay) to detect multidrug-resistant tuberculosis.

Kipiani M, Mirtskhulava V, Tukvadze N, Magee M, Blumberg HM, Kempker RR.

Clin Infect Dis. 2014 Dec 1;59(11):1559-66. doi: 10.1093/cid/ciu631. Epub 2014 Aug 4.

28.

Optimizing multiplex SNP-based data analysis for genotyping of Mycobacterium tuberculosis isolates.

Sengstake S, Bablishvili N, Schuitema A, Bzekalava N, Abadia E, de Beer J, Tadumadze N, Akhalaia M, Tuin K, Tukvadze N, Aspindzelashvili R, Bachiyska E, Panaiotov S, Sola C, van Soolingen D, Klatser P, Anthony R, Bergval I.

BMC Genomics. 2014 Jul 7;15:572. doi: 10.1186/1471-2164-15-572.

29.

Diabetes mellitus, smoking status, and rate of sputum culture conversion in patients with multidrug-resistant tuberculosis: a cohort study from the country of Georgia.

Magee MJ, Kempker RR, Kipiani M, Tukvadze N, Howards PP, Narayan KM, Blumberg HM.

PLoS One. 2014 Apr 15;9(4):e94890. doi: 10.1371/journal.pone.0094890. eCollection 2014.

30.

Performance of the MTBDRsl assay in Georgia.

Tukvadze N, Bablishvili N, Apsindzelashvili R, Blumberg HM, Kempker RR.

Int J Tuberc Lung Dis. 2014 Feb;18(2):233-9. doi: 10.5588/ijtld.13.0468.

31.

Favorable outcomes for multidrug and extensively drug resistant tuberculosis patients undergoing surgery.

Vashakidze S, Gogishvili S, Nikolaishvili K, Dzidzikashvili N, Tukvadze N, Blumberg HM, Kempker RR.

Ann Thorac Surg. 2013 Jun;95(6):1892-8. doi: 10.1016/j.athoracsur.2013.03.067. Epub 2013 May 1.

32.

A culture-specific nutrient intake assessment instrument in patients with pulmonary tuberculosis.

Frediani JK, Tukvadze N, Sanikidze E, Kipiani M, Hebbar G, Easley KA, Shenvi N, Ramakrishnan U, Tangpricha V, Blumberg HM, Ziegler TR.

Clin Nutr. 2013 Dec;32(6):1023-8. doi: 10.1016/j.clnu.2013.02.013. Epub 2013 Mar 5.

33.

Use of a molecular diagnostic test in AFB smear positive tuberculosis suspects greatly reduces time to detection of multidrug resistant tuberculosis.

Tukvadze N, Kempker RR, Kalandadze I, Kurbatova E, Leonard MK, Apsindzelashvili R, Bablishvili N, Kipiani M, Blumberg HM.

PLoS One. 2012;7(2):e31563. doi: 10.1371/journal.pone.0031563. Epub 2012 Feb 9.

34.

Effects of sunlight and diet on vitamin D status of pulmonary tuberculosis patients in Tbilisi, Georgia.

Desai NS, Tukvadze N, Frediani JK, Kipiani M, Sanikidze E, Nichols MM, Hebbar G, Kempker RR, Mirtskhulava V, Kalandadze I, Seydafkan S, Sutaria N, Chen TC, Blumberg HM, Ziegler TR, Tangpricha V.

Nutrition. 2012 Apr;28(4):362-6. doi: 10.1016/j.nut.2011.08.012. Epub 2012 Feb 2.

Supplemental Content

Loading ...
Support Center